Digest Network Come funziona
Network
/
Società
bi
Non verificato

bioAffinity Technologies, Inc.

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaOncologiaSaluteScienza

76 comunicati stampa

Guarda tutti i comunicati
28/04/2026
Industria
Tecnica
Scienza
Medicina - Varie
Software
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
14/04/2026
Industria
Tecnica
Scienza
Medicina - Varie
Software
Biotecnologia
Salute
Oncologia
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
07/04/2026
Eventi
Fiere
Industria
Software
Biotecnologia
Oncologia
Salute
Attrezzature medico-sanitarie
Tecnica
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
01/04/2026
Pubblico Esercizio/Vendita al dettaglio
Industria
Software
Biotecnologia
Oncologia
Salute
Attrezzature medico-sanitarie
Tecnica
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
25/03/2026
Web e Social Network
Industria
Scienza
Medicina nucleare
Biotecnologia
Oncologia
Salute
Medicina - Varie
Sanità
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
17/03/2026
Industria
Scienza
Tecnica
Medicina - Varie
Software
Biotecnologia
Farmaceutica
Salute
Oncologia
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
13/03/2026
Mercato azionario
Industria
Scienza
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
10/03/2026
Industria
Scienza
Tecnica
Medicina - Varie
Software
Biotecnologia
Farmaceutica
Salute
Oncologia
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
03/03/2026
Eventi
Industria
Scienza
Tecnica
Medicina - Varie
Software
Biotecnologia
Farmaceutica
Salute
Oncologia
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
25/02/2026
Industria
Medicina nucleare
Farmaceutica
Medicina - Varie
Oncologia
Attrezzature medico-sanitarie
Difesa / Forze Armate
Sanità
Biotecnologia
Scienza
Salute
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0